Media Digest 2/14/2007 Reuters, WSJ, NYTimes, Barron’s FT
According to Reuters, the FDA is trying to promote a culture that will allow dissenting opinions within the agency when it reviews new drugs.Reuters writes that Wall St. is skeptical ...Read Full Story »





